|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 22, 2016 ) The advances in neurological applications and development of new products by the companies are supporting to address the demand for cost effectiveness of radiopharmaceuticals. Nuclear medicine imaging procedures are non-invasive and can be used for the treatment of several diseases, such as cancers, cardiovascular diseases, and neurological disorders.
Explore more or request TOC on Global Nuclear Medicine (Radiopharmaceuticals) Market at: https://www.psmarketresearch.com/market-analysis/nuclear-medicine-market
Use of alpha radio immunotherapy for treatment of oncological disorders and use of nuclear medicine or radiopharmaceuticals with conventional diagnostics imaging systems, such as computed tomography (CT) scan and magnetic resonance imaging (MRI) scan, are the major trends in the global nuclear medicine/radiopharmaceuticals market. Nuclear medicine procedures help in diagnosis of a disease with detailed and accurate results in its early stage, i.e. often before symptoms occur. Nuclear medicine tests are pain less and provide information about specific organs with minimum amount of radiation; this in turn helps physicians to treat a wide range of diseases, such as cancer, bone metastasis, and thyroid.
Some of the factors driving the growth of nuclear medicine/radiopharmaceuticals market are increasing prevalence of chronic diseases, technological advancements, increasing healthcare expenditure, and increasing demand of radiopharmaceuticals in emerging economies. In addition, rising awareness of radiopharmaceuticals among healthcare providers also fuels growth of the global nuclear medicine/radiopharmaceuticals market. However, stringent regulatory approvals, high cost of devices using radioisotopes, short half-life of radiopharmaceuticals and availability of conventional diagnostics procedures are some of the factors restraining the growth of the nuclear medicine/radiopharmaceuticals market to some extent.
Geographically, North America will be leading the global nuclear medicine/radiopharmaceuticals market in the coming years due to increasing prevalence of cancer, ready availability of radiopharmaceuticals, popularity of nuclear medicine among physicians, and technological advancements. Asia-Pacific is the fastest growing region in the global nuclear medicine/radiopharmaceuticals market. The major reasons for the fastest growth in the region are increasing healthcare expenditure, and rising awareness of radiopharmaceuticals among healthcare providers. Moreover, Japan will be leading the nuclear medicine/radiopharmaceuticals market in Asia-Pacific region in the coming years.
Browse related market research at: https://www.psmarketresearch.com/industry-report/healthcare
Some of the major players operating in the global nuclear medicine/radiopharmaceuticals market are GE Healthcare, Bayer Healthcare, Cardinal Health Inc., Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.p.A, Nordion Inc., Lantheus Medical Imaging Inc., Advanced Accelerator Applications S.A, Mallinckrodt plc, and IBA Molecular Imaging.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
P&S Market Research
Abhishek
1-888-778-7886
enquiry@psmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
